Physiol. Genomics Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Physiol. Genomics (June 12, 2007). doi:10.1152/physiolgenomics.00019.2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
31/1/32    most recent
00019.2007v2
00019.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hameyer, D.
Right arrow Articles by Bockamp, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hameyer, D.
Right arrow Articles by Bockamp, E.
Submitted on January 20, 2007
Accepted on April 4, 2007

Toxicity of ligand-dependant Cre-recombinases and generation of a conditional Cre-deleter mouse allowing mosaic recombination in peripheral tissues

Dorothe Hameyer1, Ate Loonstra2, Leonid Eshkind1, Steffen Schmitt3, Cecilia Antunes1, Annemiek Groen4, Eric Bindels2, Jos Jonkers5, Paul Krimpenfort2, Ralph Meuwissen2, Loes Rijswijk4, Axel Bex2, Anton Berns2, and Ernesto Bockamp1*

1 Institute of Toxicology/Mousegenetics, Johannes Gutenberg-Universitat Mainz, Germany
2 Division of Molecular Genetics and Center of Biomedical Genetics, The Netherlands Cancer Institute, Amsterdam, Netherlands
3 FACS and Array Core Facility, Johannes Gutenberg-Universitat Mainz, Mainz, Germany
4 Academic Medical Center, AMC Liver Center, The Netherlands Cancer Institute, Amsterdam, Netherlands; Division of Molecular Genetics and Center of Biomedical Genetics, The Netherlands Cancer Institute, Amsterdam, Netherlands
5 Division of Molecular Biology, The Netherlands Cancer Institute, Amsterdam, Netherlands

* To whom correspondence should be addressed. E-mail: bockamp{at}mail.uni-mainz.de.

Ligand-activated Cre recombinases are widely used for studying gene function in vitro and in conditional mouse models. To compare ligand-dependent Cre recombinases, different Cre estrogen receptor fusions were introduced into the ROSA26 locus of embryonic stem (ES) cells and assayed for genotoxicity and recombination efficiency. Of the tested recombinases, the CreERT2 variant showed no toxicity and was highly responsive to ligand induction. To constitutively express CreERT2 in mice and to also clarify if the CreERT2 system displays background activity, we generated a knock-in mouse line harbouring the CreERT2 coding region under the control of the ROSA26 locus. Analysis of this ROSA26 CreERT2 deleter mouse with different reporter strains revealed ubiquitous recombination in the embryo, partial recombination in peripheral and haematopoietic tissues but no effective CreERT2 expression in the brain. Furthermore, using flow cytometry we found low level background recombination in non-induced bi-transgenic ROSA26 CreERT2/EGFP reporter mice. To determine whether background activity poses a general problem for conducting conditional in vivo experiments with the ROSA26 CreERT2 deleter, we used a sensitive conditional skin cancer model. In this assay cancer induction was completely restricted to induced bi-transgenic CreERT2/K-RasV12 mice whereas non-induced control animals did not show any sign of cancer indicating the usefulness of the ROSA CreERT2 system for regulating conditional gene expression in vivo. The ROSA26 CreERT2 deleter strain will be a convenient experimental tool for studying gene function under circumstances requiring partial induction of recombination in peripheral tissues and will be useful for uncovering previously unknown or unsuspected phenotypes.




This article has been cited by other articles:


Home page
J. Immunol.Home page
A. Uhmann, K. Dittmann, J. Wienands, and H. Hahn
Comment on "Direct Hematological Toxicity and Illegitimate Chromosomal Recombination Caused by the Systemic Activation of CreERT2"
J. Immunol., September 1, 2009; 183(5): 2891 - 2891.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. G. Crist, D. Montarras, G. Pallafacchina, D. Rocancourt, A. Cumano, S. J. Conway, and M. Buckingham
Muscle stem cell behavior is modified by microRNA-27 regulation of Pax3 expression
PNAS, August 11, 2009; 106(32): 13383 - 13387.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. Zibat, A. Uhmann, F. Nitzki, M. Wijgerde, A. Frommhold, T. Heller, V. Armstrong, L. Wojnowski, L. Quintanilla-Martinez, J. Reifenberger, et al.
Time-point and dosage of gene inactivation determine the tumor spectrum in conditional Ptch knockouts
Carcinogenesis, June 1, 2009; 30(6): 918 - 926.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. R. Horman, C. S. Velu, A. Chaubey, T. Bourdeau, J. Zhu, W. E. Paul, B. Gebelein, and H. L. Grimes
Gfi1 integrates progenitor versus granulocytic transcriptional programming
Blood, May 28, 2009; 113(22): 5466 - 5475.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. S. Velu, A. M. Baktula, and H. L. Grimes
Gfi1 regulates miR-21 and miR-196b to control myelopoiesis
Blood, May 7, 2009; 113(19): 4720 - 4728.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.